Absract- AACR - The dual P13KmTOR-pathway inhibitor-GDC-0084 achieves antitumor activity in PIK3CA-mutant breast cancer brain metastases.
Recently published online the 22 February 2019 by American Association for Cancer Research.
Thank you Associate Professor Priscilla Brastianos for your dedication.
Regards.
http://clincancerres.aacrjournals.org/content/early/2019/02/22/1078-0432.CCR-18-3049
Absract- AACR - The dual P13KmTOR-pathway inhibitor-GDC-0084...
Add to My Watchlist
What is My Watchlist?